Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Karalezli, E. Parlak, A. Senturk, H. C. Hasanoglu (Ankara, Turkey). Homocysteine and serum-lipide levels in pulmonary thromboembolism. Eur Respir J 2008; 32: Suppl. 52, 1053

Member's Comments

No comment yet.

Related content which might interest you: The prevalence of hyperhomocysteinemia in venous thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 48s Year: 2006 Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 Venous thromboembolism and arterial atherosclerosis: a bidirectional association Source: Virtual Congress 2020 – Cardiovascular morbidity and mortality after pulmonary embolism Year: 2020 Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Factors predicting pulmonary artery pressure after acute pulmonary thromboembolism Source: Eur Respir J 2001; 18: Suppl. 33, 380s Year: 2001 Incidence of recurrent thromboembolism and chronic thromboembolic pulmonary hypertension after pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Incidence of venous thromboembolism in COPD: linking inflammation and thrombosis? Source: Eur Respir J 2016; 47: 369-373 Year: 2016 Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012 Clinical presentation and outcome of venous thromboembolism in COPD Source: Eur Respir J 2012; 39: 862-868 Year: 2012 Chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Update on venous thromboembolism Year: 2007 Fibrinogen plasma levels and disease severity in pulmonary artery hypertension Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Venous thromboembolism in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2004; 23: 637-648 Year: 2004 Platelets and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Asthma and risk of pulmonary thromboembolism Source: Eur Respir J 2014; 43: 1534-1535 Year: 2014 Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2009; 33: 332-338 Year: 2009 Analysis of risk factors in pulmonary thromboembolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006 Plasma metabolomics in chronic thromboembolic pulmonary hypertension Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021